Nord C E
Department of Microbiology, Karolinska Institute, Huddinge University Hospital, Stockholm, Sweden.
Rev Infect Dis. 1989 Jul-Aug;11 Suppl 5:S1287-91. doi: 10.1093/clinids/11.supplement_5.s1287.
Intraabdominal infections occur after trauma, surgical resections, or development of intrinsic diseases of the gastrointestinal tract. These infections, which may be generalized or localized in intraperitoneal or extraperitoneal locations and in organs, are often difficult to diagnose and treat. The infections are usually polymicrobial and can involve both aerobic and anaerobic microorganisms. Adequate surgical drainage and antimicrobial therapy improve the clinical course and reduce the risk of septicemia and local complications. There are only a few studies published to date concerning the use of the new quinolones for surgical prophylaxis and treatment of surgical infections. On the basis of these studies, it can be concluded that surgical infections due to enterobacteria and staphylococci may be successfully treated with the new quinolones. When streptococci or anaerobic bacteria are involved, antimicrobial agents effective against these microorganisms must be added.
腹腔内感染发生于创伤、手术切除或胃肠道自身疾病之后。这些感染可能是全身性的,也可能局限于腹膜内或腹膜外部位以及器官,常常难以诊断和治疗。感染通常是多微生物的,可涉及需氧菌和厌氧菌。充分的手术引流和抗菌治疗可改善临床病程,降低败血症和局部并发症的风险。迄今为止,关于新型喹诺酮类药物用于手术预防和治疗手术感染的研究仅有少数几项。基于这些研究,可以得出结论,由肠杆菌和葡萄球菌引起的手术感染可用新型喹诺酮类药物成功治疗。当涉及链球菌或厌氧菌时,必须添加对这些微生物有效的抗菌药物。